Authors:
MARSH DJ
COULON V
LUNETTA KL
ROCCASERRA P
DAHIA PLM
ZHENG ZM
LIAW D
CARON S
DUBOUE B
LIN AY
RICHARDSON AL
BONNETBLANC JM
BRESSIEUX JM
CABARROTMOREAU A
CHOMPRET A
DEMANGE L
EELES RA
YAHANDA AM
FEARON ER
FRICKER JP
GORLIN RJ
HODGSON SV
HUSON S
LACOMBE D
LEPRAT F
ODENT S
TOULOUSE C
OLOPADE OI
SOBOL H
TISHLER S
WOODS CG
ROBINSON BG
WEBER HC
PARSONS R
PEACOCKE M
LONGY M
ENG C
Citation: Dj. Marsh et al., MUTATION SPECTRUM AND GENOTYPE-PHENOTYPE ANALYSES IN COWDEN-DISEASE AND BANNAYAN-ZONANA-SYNDROME, 2 HAMARTOMA SYNDROMES WITH GERMLINE PTEN MUTATION, Human molecular genetics, 7(3), 1998, pp. 507-515
Citation: Jp. Fricker, A NEW SELF-CURING RESIN-MODIFIED GLASS-IONOMER CEMENT FOR THE DIRECT BONDING OF ORTHODONTIC BRACKETS IN-VIVO, American journal of orthodontics and dentofacial orthopedics, 113(4), 1998, pp. 384-386
Citation: Jp. Fricker, A 12-MONTH CLINICAL COMPARISON OF RESIN-MODIFIED LIGHT-ACTIVATED ADHESIVES FOR THE CEMENTATION OF ORTHODONTIC MOLAR BANDS, American journal of orthodontics and dentofacial orthopedics, 112(3), 1997, pp. 239-243
Authors:
CUTULI B
PETIT JC
FRICKER JP
SCHUMACHER C
VELTEN M
ABECASSIS J
Citation: B. Cutuli et al., THROMBOEMBOLIC ACCIDENTS IN POSTMENOPAUSA L PATIENTS TREATED BY TAMOXIFEN AS ADJUVANT TREATMENT - FREQUENCY, RISK-FACTORS AND PREVENTION, Bulletin du cancer, 82(1), 1995, pp. 51-56
Authors:
CUTULI BF
PETIT JC
FRICKER JP
JUNG GM
SCHUMACHER C
VELTEN M
ABECASSIS J
Citation: Bf. Cutuli et al., ADJUVANT TAMOXIFEN IN BREAST-CANCER-TREATMENT IN POSTMENOPAUSAL WOMEN- OCCURRENCE OF THROMBOEMBOLIC COMPLICATIONS, Oncology Reports, 1(1), 1994, pp. 59-63
Citation: Jp. Fricker, A 12-MONTH CLINICAL-EVALUATION OF A LIGHT-ACTIVATED GLASS POLYALKENOATE (IONOMER) CEMENT FOR THE DIRECT BONDING OF ORTHODONTIC BRACKETS, American journal of orthodontics and dentofacial orthopedics, 105(5), 1994, pp. 502-505
Authors:
FRICKER JP
KHER A
VERGNES Y
HEITZ A
SCHACH R
RODIER JF
JANSER JC
Citation: Jp. Fricker et al., 10 DAYS OR 20 DAYS PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ONCOLOGICAL SURGERY BY A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN-R), Thrombosis and haemostasis, 69(6), 1993, pp. 1113-1113
Authors:
LALLE P
STOPPALYONNET D
MAZOYER S
RIO P
GIRODET C
HARDOUIN A
NAROD SA
SOBOL H
BIGNON YJ
LARRA F
LORTHOLARY A
PIET L
LAITHIER V
VUILLIER J
DILHUYDY MH
LONGY M
TOULOUSE C
COUETTE JE
HARDOUIN A
SWITSUS O
CHAMOUTON C
BIGNON YJ
PLAGNE R
PETIT MF
CURE H
CUISENIER J
LIZARD S",NIVELON,"TEYSSIER JY",MOUSSEAU,"LEROUX D",VROUSOS,SCHAERER,"VENNIN P
DEMAILLE MC
DECIGNY N
GRANIER AM
DEYRAT JP
SOBOL H
DESSEIGNE F
FRAPPAZ D
FERVERS B
EISINGER F",FABBRO,"LUPORSI E
LEHEUP B
SOMMELET D
MAUGAUDLOUBOUTIN C
FRENAY M
GESTA P
THOMAS G
OLSCHWANG S
DELETTRE O
AURIAS A",ZUMMER,"HAGUENAUER O
GRANDJOUAN S
DEMANGE L
DANELMOORE L
LEVEQUE J
NOGUES C
PETIT JC
FRICKER JP
LIMACHER JM
ROUMAGNAC M
LAPEYRE M
DREYFUS HR
GRANDJOUAN S
SCHLUMBERGER M
BRUGIERES L
JANIN N
AVRIL MF
Citation: P. Lalle et al., GENETIC PREDISPOSITION TO BREAST-CANCER A ND OVARIAN-CANCER, Bulletin du cancer, 80(10), 1993, pp. 857-865